Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Head and Neck Neoplasms 43Thyroid Neoplasms 18Thyroid Nodule 7Squamous Cell Carcinoma of Head and Neck 7Mouth Neoplasms 7Lung Neoplasms 6Thyroid Diseases 5Neoplasm Metastasis 5Goiter 5Pain, Postoperative 4Nasopharyngeal Neoplasms 4Nasopharyngeal Carcinoma 4Carcinoma, Renal Cell 4Breast Neoplasms 4Parathyroid Neoplasms 3Pancreatic Neoplasms 3Oropharyngeal Neoplasms 3Mucositis 3Melanoma 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Agnosia 3Xerostomia 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Tobacco Use Disorder 2Thyroid Cancer, Papillary 2Stomatitis 2Stomach Neoplasms 2

Interventions

trametinib 1selpercatinib 1pralsetinib 1lenvatinib 1larotrectinib 1entrectinib 1dabrafenib 1anlotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Advanced Thyroid Cancer Patients Who Received Target Therapy × Head & Neck × Clear all
NCT06195228 2025-08-14

A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid Cancer

Fudan University

Phase 4 Recruiting
800 enrolled
EndocrineHead & Neck

Advanced Thyroid Cancer Patients Who Received Target Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡